Anzeige
Meldung des Tages: Deep-Value-Chance: 60 % Insideranteil – warum dieser Gold-Explorer als Geheimtipp gilt

Neurogene Aktie News

Aktie
WKN:  A3EX79 ISIN:  US64135M1053 US-Symbol:  NGNE Branche:  Biotechnologie Land:  USA
15,15 €
+0,60 €
+4,12%
15:25:01 Uhr
Depot/Watchlist
Marktkapitalisierung *
34,59 Mio. €
Streubesitz
-
KGV
-5,37
Index-Zuordnung
-

Neurogene News

04.02.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neurogene Inc. - NGNE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neurogene Inc. - NGNE PR Newswire
28.01.25 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neurogene Inc. - NGNE
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neurogene Inc. - NGNE PR Newswire
21.01.25 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neurogene Inc. - NGNE
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neurogene Inc. - NGNE PR Newswire
02.01.25 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neurogene Inc. - NGNE
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neurogene Inc. - NGNE PR Newswire
27.12.24 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neurogene Inc. - NGNE
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neurogene Inc. - NGNE PR Newswire
03.12.24 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neurogene Inc. - NGNE
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neurogene Inc. - NGNE PR Newswire
25.11.24 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neurogene Inc. - NGNE
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neurogene Inc. - NGNE PR Newswire
18.11.24 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neurogene Inc. - NGNE
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neurogene Inc. - NGNE PR Newswire
22.08.23 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HCCI, CCF, SCU, NLTX
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HCCI, CCF, SCU, NLTX PR Newswire
15.08.23 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRDS, CCF, NLTX, SCU
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRDS, CCF, NLTX, SCU PR Newswire
07.08.23 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMNB, CCF, NLTX, SCU
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMNB, CCF, NLTX, SCU PR Newswire
01.08.23 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AJX, DEN, FREQ, NLTX
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AJX, DEN, FREQ, NLTX PR Newswire
24.07.23 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SCU, PRDS, NLTX, AJX
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SCU, PRDS, NLTX, AJX PR Newswire
18.07.23 - PR Newswire
Shareholder Alert: Ademi LLP investigates whether Neoleukin Therapeutics, Inc. has obtained a Fair Price in its Private Placement and its transaction with Neurogene
Shareholder Alert: Ademi LLP investigates whether Neoleukin Therapeutics, Inc. has obtained a Fair Price in its Private Placement and its transaction with Neurogene PR Newswire
18.07.23 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DEN, NLTX, FREQ
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DEN, NLTX, FREQ PR Newswire
22.07.18 - sharedeals.de
Aquinox: Erste NBC-Empfehlung mit +40% in drei Wochen
Schon in den ersten Wochen zeigt sich der weltweit einmalige Wert des hochexklusiven No Brainer Clubs: Mit Aquinox Pharmaceuticals (WKN: A1XDJL) gewinnt die erste NBC-...
20.07.18 - sharedeals.de
Aquinox: Erste NBC-Empfehlung mit +40% in drei Wochen
Schon in den ersten Wochen zeigt sich der weltweit einmalige Wert des hochexklusiven No Brainer Clubs: Mit Aquinox Pharmaceuticals (WKN: A1XDJL) gewinnt die erste NBC-...

Newssuche

Videos

newspaper
20:00 Uhr
2026 02 03 17 34 Trendjumper Einführung
Zunächst inormieren wir unsere Stammkunden bezüglich des bevorstehenden Seminars und bieten für ... Mehr »